Treatment of type 1 diabetes mellitus by M2 polarization of macrophages in pancreas

A method for polarizing a macrophage into an M2 macrophage is disclosed. Methods for treating type 1 diabetes in a subject are also disclosed. The methods comprise administering to a subject a vector comprising a macrophage-specific promoter operably linked to a nucleic acid molecule encoding a TNF-...

Full description

Saved in:
Bibliographic Details
Main Authors GEERTS GERRIT, XIAO XIANGWEI
Format Patent
LanguageChinese
English
Published 06.12.2022
Subjects
Online AccessGet full text

Cover

More Information
Summary:A method for polarizing a macrophage into an M2 macrophage is disclosed. Methods for treating type 1 diabetes in a subject are also disclosed. The methods comprise administering to a subject a vector comprising a macrophage-specific promoter operably linked to a nucleic acid molecule encoding a TNF-alpha induced protein 8-like 2 (TIPE2) protein. In some embodiments, a carrier is topically administered to the pancreas of a subject. In a further embodiment, disclosed is a composition comprising a) a vector comprising a macrophage specific promoter operably linked to a nucleic acid molecule encoding a TNF-alpha induced protein 8-like 2 (TIPE2) protein; b) a buffer solution; and c) a contrast dye for endoscopic retrograde cholangiopancreatography. 公开了用于将巨噬细胞极化成M2巨噬细胞的方法。还公开了用于治疗受试者的1型糖尿病的方法。这些方法包括向受试者施用载体,该载体包含可操作地连接至编码TNF-α诱导的蛋白8样2(TIPE2)蛋白的核酸分子的巨噬细胞特异性启动子。在一些实施方案中,将载体局部施用至受试者的胰腺。在进一步的实施方案中,公开了组合物,该组合物包括a)载体,该载体包含可操作地连接至编码TNF-α诱导的蛋白8样2(TIPE2)蛋白的核酸分子的巨噬细胞特异性启动子;b)缓冲液;和c)用于内窥镜逆行胰胆管造影的造影染料。
Bibliography:Application Number: CN20208089229